Targeted molecular therapies represent a groundbreaking approach in the fight against cancer, focusing on the intricate interplay between genetic mutations and protein interactions.These innovative small molecule drugs are designed to selectively target specific pathways within cancer cells, effectively disrupting their uncontrolled growth.